Water for Pharmaceutical Use

Slides:



Advertisements
Similar presentations
Supplementary Training modules on Good Manufacturing Practices
Advertisements

World Health Organization
Supplementary Training Modules on Good Manufacturing Practice
Radiopharmaceutical Production
© WHO – PSM Quality Control Laboratory Pharmaceutical Quality, Good manufacturing Practice & Bioequivalence Kiev, Ukraine October 2005 Maija Hietava.
WHO - PSM Water –part 3 Workshop on GMP and Quality Assurance of HIV products Shanghai, China 28 Feb - 4 March 2005 Maija Hietava M.Sci.Pharm Quality Assurance.
EG Medical Systems Maintenance BU MEDICAL SYSTEMS Service Department Scope  Service Department offers after sales service for products sold by EG Medical.
World Health Organization
EQUIPMENT VALIDATION.
Overview of Validation Requirements Pharmaceutical Industry
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
World Health Organization
Lecture 8. Quality Assurance/Quality Control The Islamic University of Gaza- Environmental Engineering Department Environmental Measurements (EENV 4244)
World Health Organization
Pharmaceutical Product Quality Assurance Through CMC Drug Development Process Presented by Darlene Rosario (Aradigm) 21 October 2003 Meeting of the Advisory.
Supplementary Training Modules on Good Manufacturing Practice
Quality Assurance/Quality Control Policy
Water | Slide 1 of 16 January 2006 Water for Pharmaceutical Use Part 4: Commissioning, Qualification and validation Supplementary Training Modules on Good.
VALIDATION OF WATER SUPPLY SYSTEM
Validation.
Validation SAPRAA March 2013.
Pharmaceutical Water Systems Alain Kupferman Manufacture of sterile medicines – Advanced workshop for SFDA GMP inspectors, Nanjing, November 2009.
World Health Organization
WHO Supplementary Training Modules GMP
Qualification of HVAC systems
QC | Slide 1 of 16 June 2006 Good Practices for Quality Control Laboratories P art 4: Inspecting the laboratory Supplementary Training Modules on Good.
Qualification and Validation
MCC PRESENTATION - GMP MANUFACTURING ENVIRONMENTS
EQUIPMENT QUALIFICATION/VALIDATION
Seafood HACCP Alliance for Training and Education Chapter 10 Principle 6: Establish Verification Procedures.
A Seminar on 1.  Why to validate?  Parts of Equipment Validation  Who should do Equipment Validation?  Equipment qualification  Typical process flow.
World Health Organization
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
VALIDATION METHODOLOGY
Part 3: Design, qualification
Water | Slide 1 of Water for Pharmaceutical Use Part 3: Operational considerations Supplementary Training Modules on Good Manufacturing Practice.
Equipment Management Audience – Local lab responsibilities.
World Health Organization
FDA Recommendations: Sampling Plans for Blood Establishments Lore Fields MT(ASCP)SBB Consumer Safety Officer OBRR/CBER/FDA October 19, 2012.
Important informations
July LEReC Review July 2014 Low Energy RHIC electron Cooling Edward T. Lessard ESHQ.
Basic Principles of GMP
Module 1,, Part 5: Review and summary Slide 1 of 13 © WHO – EDM Validation Part 5: Review and summary Supplementary Training Modules on Good Manufacturing.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Validation | Slide 1 of 27 August 2006 Validation Supplementary Training Modules on Good Manufacturing Practice WHO Technical Report Series, No. 937, 2006.
MANUFACTURING AND PRODUCTION OF BIOLOGICAL PRODUCTS (ERT 455)
Module 4Slide 1 of 23 WHO - EDM Validation Basic Principles of GMP.
Problem Management Scenario # 2 September 17,2005.
Pharmaceutical Quality Control & current Good Manufacturing Practice
ERT 421 Good Manufacturing Practice for Bioprocess Engineering Test 1: answer scheme.
Quality is the totality of features and characteristics of product or services that bear on its ability to satisfy the stated needs.  In simple words.
1. Our Presentation Topic: Importance Of Validation & Qualification In Pharmaceutical Industries Presented By: Md. Tanjir Islam (Group C) 2.
HOLD-TIME STUDIES.
BSB Biomanufacturing CHAPTER 4 GMP – Documentation Part I (SOP)
Qualification And Validation In Pharmaceutical Manufacturing
World Health Organization
Pharmaceutical Quality Control & current Good Manufacturing Practice
Author: Nurul Azyyati Sabri
QUALITY ASSURANCE AND QUALITY CONTROL IN GENERICS
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
Autotest – Calibrated Leak
Quality Assurance and Quality Control in Generics
Quality Systems in a Production Facility
ולידציה מול כיול-השונה והדומה
יוסי שדמתי רק איכות מניהול סיכונים לאימות ותיקוף תהליכי הרכבה From Risk Management to Processes Validation יוסי.
World Health Organization
World Health Organization
Computer System Validation
Pharmaceutical Quality System in regard to Good Engineering Practice
Presentation transcript:

Water for Pharmaceutical Use Commissioning, Qualification and Validation Presented by Mrs. Chizoba Maduagwuna (B. Pharm.) December 2016, Lagos, Nigeria Chizoba.maduagwuna@nafdac.gov.ng 080-66781677

Water for Pharmaceutical Use Commissioning, Qualification and Validation

Water for Pharmaceutical Use Objectives To discuss the operational considerations of water systems including: Start up, commissioning and qualification Monitoring Maintenance System reviews

Water for Pharmaceutical Use Start up and commissioning Precursor to qualification and validation Should be planned, well defined, well documented Includes setting to work Includes system set-up Includes recording of system performance parameters Controls loop tuning

Water for Pharmaceutical Use Qualification WPU systems are "direct impact systems" Therefore stages to be considered in qualification should include DQ, IQ, OQ, PQ DQ: Design review influenced by source water and required water quality IQ: Installation verification of the system

Water for Pharmaceutical Use Qualification OQ: operational qualification Presentation focusing on PQ PQ demonstrates consistent and reliable performance of the system Three phase approach recommended over extended period – proves reliability and robustness

Water for Pharmaceutical Use Phase 1 (1) A test period of 2-4 weeks – monitoring the system intensively System to operate continuously without failure or performance deviation The following should be included in the testing approach Undertake chemical and microbiological testing in accordance with a defined plan

Water for Pharmaceutical Use Phase 1 (2) Sample daily: incoming feed-water after each step in the purification process each point of use and at other defined sample points Develop: appropriate operating ranges and finalize operating, cleaning, sanitizing and maintenance procedures

Water for Pharmaceutical Use Phase 1 (3) Demonstrate production and delivery of product water of the required quality and quantity Use and refine the standard operating procedures (SOPs) for operation, maintenance, sanitization and troubleshooting Verify provisional alert and action levels Develop and refine test-failure procedure

Water for Pharmaceutical Use Phase 2. (1) A further test period of 2-4 weeks – further intensive monitoring the system Deploying all the refined SOPs after the satisfactory completion of phase 1 Sampling scheme generally the same as in phase 1 Water can be used for manufacturing purposes during this phase

Water for Pharmaceutical Use Phase 2. (2) Demonstrate: Consistent operation within established ranges Consistent production and delivery of water of the required quantity and quality when the system is operated in accordance with the SOPs

Water for Pharmaceutical Use Phase 3. Over 1 year after the satisfactory completion of phase 2 Water can be used for manufacturing purposes during this phase Demonstrate: extended reliable performance that seasonal variations are evaluated Sample locations, sampling frequencies and tests should be reduced to the normal routine pattern based on established procedures proven during phases 1 and 2

Water for Pharmaceutical Use Ongoing system monitoring After phase 3 – system review needed Based on review including results, establish a routine monitoring plan Monitoring to include a combination of on-line monitoring and off-line sample testing Data analysed for trends

Water for Pharmaceutical Use Ongoing system monitoring (2) Monitoring parameters to include: Flow, pressure, temperature, conductivity, TOC Samples taken: From points of use, and specific sample points In a similar way how water is used in service Tests to include physical, chemical and microbial attributes

Water for Pharmaceutical Use Maintenance A controlled, documented maintenance programme covering: Defined frequency with plan and instructions Calibration programme SOPs for tasks Control of approved spares Record and review of problems and faults during maintenance

Water for Pharmaceutical Use System review WPU (PW, HPW and WFI) systems to be reviewed at appropriate regular intervals Review team includes engineering, QA, operations and maintenance

Water for Pharmaceutical Use System review (2) The review to cover, e.g. changes made since the last review system performance reliability quality trends failure events investigations out-of-specifications results from monitoring changes to the installation updated installation documentation log books the status of the current SOP lists

THANK YOU!